Whether detecting cancer, heart or brain imaging, renal exams or bone scans, physicians must be able to rely on their PET-CT or SPECT-CT scanners. Any system downtime costs molecular imaging (MI) customers significantly, as an expensive radiopharmaceutical dose must be ordered specifically for each patient in advance of the examination. In order to help assure the highest availability of the scanners, Siemens has extended its Guardian Program to a variety of MI systems. Proactive online monitoring in real-time now is available for the MI system families Biograph mCT, Biograph TruePoint, Symbia S and Symbia T.
If parameters exceed or undershoot defined critical levels, the system will proactively send a message to the Siemens Service Center. A predefined high-speed support and repair process is set into motion with clearly defined reaction and repair times as well as improved spare parts availability. In addition, a service expert will guide the customer through the first critical phase and help re-establish the system’s availability as fast as possible. For Guardian customers this means high system reliability and availability, reduction of unscheduled downtimes, proactive rescheduling of patients and staff, and potentially less revenue loss because downtimes can be planned ahead of time.
As an additional offering, the Siemens Guardian Program including TubeGuard can now predict the majority of all potential CT tube failures within the Siemens MI system BiographmCT. More than ten sensors proactively monitor the tube functions via real-time data flow with Siemens Remote Service (SRS).Tube exchanges can be scheduled in advance and unplanned downtime can be avoided. The CT tube is absolutely vital to system availability and image quality. The tube can fail – with no clear warning signs for the customer.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros.
The here mentioned products are not commercially available in all countries. Due to regulatory reasons the future availability in any country cannot be guaranteed. Please contact your local Siemens organization for further details.
Florian Gersbach | Siemens Healthcare
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Earth Sciences
07.12.2016 | Earth Sciences
07.12.2016 | Materials Sciences